See What HealthDay Can Do For You
Contact Us

~40 Percent of Docs Acquiesce to Demand for Brand-Name Rx

Being in practice for longer, small practice linked to acquiescence even when generic drugs available

WEDNESDAY, Jan. 9 (HealthDay News) -- Close to 40 percent of physicians sometimes or often acquiesce to patient demands for brand-name drugs, even when generic drugs are available, according to a research letter published online Jan. 7 in JAMA Internal Medicine.

Eric G. Campbell, Ph.D., from Harvard Medical School in Boston, and colleagues examined data from a national survey of 1,891 participants (64 percent response rate) in a random sample of 2,938 physicians in seven specialties, to assess the frequency with which physicians comply with patient requests to prescribe brand-name drugs when generic drugs are available.

The researchers found that, among all respondents, 37 percent sometimes or often prescribed a brand-name drug instead of a generic drug. Factors associated with this acquiescence included being in practice more than 30 years versus 10 years or less (43 versus 31 percent) and working solo or in a two-person practice versus working in a hospital or medical school setting (46 versus 35 percent). Compared with internal medicine physicians, pediatricians, anesthesiologists, cardiologists, and general surgeons were significantly less likely to acquiesce to patient demands. Physicians who sometimes or often met with industry representatives were significantly more likely to acquiesce, as were physicians who received free food and/or beverages in the work place and those who received drug samples.

"Approximately four of 10 physicians report that they sometimes or often prescribe a brand-name drug to a patient when a generic is available because the patient wanted it," the authors write. "These numbers suggest that the unnecessary costs associated with this practice to the health care system could be substantial."

Full Text (subscription or payment may be required)
Editorial 1 (subscription or payment may be required)
Editorial 2 (subscription or payment may be required)

Physician's Briefing